Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Donnem

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
BMC Clinical Pathology|January 22, 2014
The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunkThomas K Kilvaer, Eivind Smeland, Andrej Valkov, et al.
Journal of Translational Medicine|July 8, 2011
Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patientsThomas K Kilvaer, Andrej Valkov, Sveinung W Sorbye, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2010
Diverging prognostic impacts of hypoxic markers according to NSCLC histologySigve Andersen, Marte Eilertsen, Tom Donnem, et al.
Plos One|August 26, 2015
Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-AnalysisThomas K Kilvaer, Erna-Elise Paulsen, Sigurd M Hald, et al.
Plos One|July 26, 2017
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancerSamer Al-Saad, Elin Richardsen, Thomas K Kilvaer, et al.
Sarcoma|March 29, 2012
Prognostic impacts of hypoxic markers in soft tissue sarcomaEivind Smeland, Thomas K Kilvaer, Sveinung Sorbye, et al.
Carcinogenesis|October 9, 2020
Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?Thomas K Kilvaer, Erna-Elise Paulsen, Sigve Andersen, et al.
Plos One|February 8, 2011
Prognostic impact of lymphocytes in soft tissue sarcomasSveinung W Sorbye, Thomas Kilvaer, Andrej Valkov, et al.
Scientific Reports|November 9, 2016
Fibroblast miR-210 overexpression is independently associated with clinical failure in Prostate Cancer - a multicenter (in situ hybridization) studySigve Andersen, Elin Richardsen, Line Moi, et al.
Lung Cancer (Amsterdam, Netherlands)|February 7, 2013
CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapySigurd M Hald, Roy M Bremnes, Khalid Al-Shibli, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
BMC Clinical Pathology|January 22, 2014
The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunkThomas K Kilvaer, Eivind Smeland, Andrej Valkov, et al.
Journal of Translational Medicine|July 8, 2011
Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patientsThomas K Kilvaer, Andrej Valkov, Sveinung W Sorbye, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2010
Diverging prognostic impacts of hypoxic markers according to NSCLC histologySigve Andersen, Marte Eilertsen, Tom Donnem, et al.
Plos One|August 26, 2015
Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-AnalysisThomas K Kilvaer, Erna-Elise Paulsen, Sigurd M Hald, et al.
Plos One|July 26, 2017
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancerSamer Al-Saad, Elin Richardsen, Thomas K Kilvaer, et al.
Sarcoma|March 29, 2012
Prognostic impacts of hypoxic markers in soft tissue sarcomaEivind Smeland, Thomas K Kilvaer, Sveinung Sorbye, et al.
Carcinogenesis|October 9, 2020
Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?Thomas K Kilvaer, Erna-Elise Paulsen, Sigve Andersen, et al.
Plos One|February 8, 2011
Prognostic impact of lymphocytes in soft tissue sarcomasSveinung W Sorbye, Thomas Kilvaer, Andrej Valkov, et al.
Scientific Reports|November 9, 2016
Fibroblast miR-210 overexpression is independently associated with clinical failure in Prostate Cancer - a multicenter (in situ hybridization) studySigve Andersen, Elin Richardsen, Line Moi, et al.
Lung Cancer (Amsterdam, Netherlands)|February 7, 2013
CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapySigurd M Hald, Roy M Bremnes, Khalid Al-Shibli, et al.
Pageof 10